Hamzah Z Farooq
Overview
Explore the profile of Hamzah Z Farooq including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
32
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Farooq H, Whitton L, Mwendera C, Divall P, Spitters S, Anderson J, et al.
HIV Med
. 2024 Sep;
26(1):44-69.
PMID: 39289147
Background: The COVID-19 pandemic prompted an unprecedented surge in virtual services, necessitating a rapid shift to digital healthcare approaches. This review focuses on evaluating the evidence of virtual care (VC)...
2.
Farooq H, James M, Abbott J, Oyibo P, Divall P, Choudhry N, et al.
World J Gastrointest Oncol
. 2024 Apr;
16(4):1596-1612.
PMID: 38660636
Background: Hepatitis C virus (HCV) is a blood-borne virus which globally affects around 79 million people and is associated with high morbidity and mortality. Chronic infection leads to cirrhosis in...
3.
Haigh D, Mistry D, Farooq H, Ajdukiewicz K
Infect Med (Beijing)
. 2024 Feb;
3(1):100086.
PMID: 38352920
A 68-year-old-gentleman presented with left hip pain, night sweats, fatigue, and weight loss. He had previously experienced pain with white discharge until he underwent an arthroscopic washout and reduction. The...
4.
Farooq H, Apea V, Kasadha B, Ullah S, Hilton-Smith G, Haley A, et al.
BMJ Open
. 2023 Jul;
13(7):e070666.
PMID: 37423623
Introduction: Cabotegravir and rilpivirine (CAB+RPV long-acting (LA)) is recommended as a treatment for HIV-1 allowing people living with HIV to receive 2 monthly injectable treatment, rather than daily pills. Providing...
5.
OHara R, Brown B, Hughes A, McEwan A, Birtles A, Hawker A, et al.
J Clin Virol Plus
. 2022 Jul;
2(3):100098.
PMID: 35874465
Here we describe a retrospective clinical evaluation of the QIAGEN SARS-CoV-2 Prep&Amp UM RT-PCR assay that detects SARS-CoV-2 RNA without the need for a nucleic acid eluate extraction procedure. Using...
6.
Davies E, Farooq H, Brown B, Tilston P, McEwan A, Birtles A, et al.
Clin Lab Med
. 2022 May;
42(2):161-191.
PMID: 35636820
The COVID-19 pandemic has led to the rapid development of a plethora of molecular diagnostic assays with real-time polymerase chain reaction (RT-PCR) at the forefront. In this review, we will...
7.
Farooq H, Davies E, Brown B, Whitfield T, Tilston P, McEwan A, et al.
J Infect
. 2021 Apr;
83(1):84-91.
PMID: 33892016
Objectives: SARS-CoV-2 emerged in South Asia in 2019 and has resulted in a global pandemic. Public Health England (PHE) Manchester rapidly escalated testing for SARS-CoV-2 in the highest COVID-19 incidence...
8.
Farooq H, Cirillo D, Hillemann D, Wyllie D, van der Werf M, Kodmon C, et al.
Emerg Infect Dis
. 2021 Feb;
27(3):985-987.
PMID: 33622487
We surveyed availability of phenotypic drug susceptibility testing for drug-resistant Mycobacterium tuberculosis in Europe. Of 27 laboratories, 17 tested for linezolid, 11 for clofazimine, 9 for bedaquiline, and 6 for...
9.
Farooq H, Davies E, Ahmad S, Machin N, Hesketh L, Guiver M, et al.
Int J Infect Dis
. 2020 Feb;
93:237-244.
PMID: 32004690
Background: Middle East respiratory syndrome coronavirus (MERS-CoV) emerged in Saudi Arabia in 2012 and caused an epidemic in the Middle East. Public Health England (PHE) Manchester is one of the...